Picture of Kohjin Bio logo

177A — Kohjin Bio News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Table: Kohjin Bio -2024/25 group results

May 14 (Reuters)- 
          Kohjin Bio Co., Ltd. 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to       NEXT   
              Mar 31, 2025    Mar 31, 2024   Mar 31, 2026     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales           5.21            4.77           5.68                  
               (+9.1 pct)      (+0.6 pct)     (+9.1 pct)               
  Operating      991 mln         596 mln         1.07                  
               (+66.1 pct)     (-52.9 pct)    (+7.5 pct)               
  Recurring       1.07           635 mln         1.14                  
               (+67.6 pct)     (-48.9 pct)    (+6.6 pct)               
  Net
  Net            794 mln         384 mln        822 mln                
              (+106.4 pct)     (-53.6 pct)    (+3.5 pct)               
  EPS          157.57 yen       92.43 yen     160.85 yen               
  Ann Div       24.00 yen       14.00 yen      25.00 yen               
  -Q2 Div          NIL                            NIL                  
  -Q4 Div       24.00 yen       14.00 yen      25.00 yen               
  
  NOTE - Kohjin Bio Co., Ltd..
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=177A.T

Recent news on Kohjin Bio

See all news